The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor ...
Despite the popularity of laparoscopic donor nephrectomy, open donor nephrectomy is still widely performed. In recent years, the procedure has been refined to incorporate a muscle-sparing mini ...
The investigators observed significantly higher postoperative CTC counts in the open radical nephrectomy group compared with the other 3 groups in the study. More circulating tumor cells may enter the ...
An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for innovative imaging ...
The EVERPRO study: Final results of a non-interventional study (NIS) evaluating the quality of life (QoL) in second-line treatment of metastatic renal cell carcinoma (mRCC) with everolimus. This is an ...
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of end-stage renal failure, characterised by progressive cyst formation that distorts renal architecture and ...
Pleotrophic action of renal cell carcinoma: Dysregulated microRNAs on hypoxia-related signaling pathways. Background: Partial nephrectomy in upper pole kidney tumors represents a distinct surgical ...
Surgeons with greater skill in RAPN upon evaluation had lower rates of extended hospital stay, estimated blood loss, positive surgical margins, emergency department visits, and hospital readmissions.